Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04217122 · ClinicalTrials.gov registry record · NA
Effect of Strawberry Consumption on the Microbiome
A NA study of Microbiome, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT04217122: Completed NA study of Microbiome, sponsored by University of California, Los Angeles.
NCT04217122 is a NA study of Microbiome that has completed, run by University of California, Los Angeles. The registered enrollment target is 30 participants, below the 140-participant average among 12 other Microbiome trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04217122, a NA study of Microbiome, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This pilot study will assess the ability of daily consumption of two servings of California strawberries to alter gut microbiome composition, leading to increased bile secretion and decreased plasma cholesterol in a free-living population.
Primary Outcome
Change in phyla, genes and species of gut bacteria
Conditions Studied
Interventions
- OTHER strawberry powder
- OTHER placebo powder
Study Locations (1)
California
- UCLA Center for Human Nutrition, 1000 Veteran Ave. - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2018-09-11 |
| Est. Completion | 2019-12-19 |
| Phase | NA |
What the finished NCT04217122 record still lists
NCT04217122 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 140-participant average among 12 other Microbiome trials with a reported enrollment target (79% lower).
The record links to 1 condition, with Microbiome appearing as the primary indexed condition, and to 2 interventions - of which strawberry powder is the first listed.
NCT04217122 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04217122 about?
NCT04217122 is a clinical study titled "Effect of Strawberry Consumption on the Microbiome". This pilot study will assess the ability of daily consumption of two servings of California strawberries to alter gut microbiome composition, leading to increased bile secretion and decreased plasma cholesterol in a free-living population.
What is the current status of trial NCT04217122?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2018-09-11. Estimated completion is 2019-12-19.
What conditions does trial NCT04217122 study?
This clinical trial studies the following conditions: Microbiome.
What interventions are being tested in trial NCT04217122?
The interventions under investigation include: strawberry powder (OTHER), placebo powder (OTHER).
Who is sponsoring clinical trial NCT04217122?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04217122 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Microbiome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04217122's enrollment target sits among peer trials
30 12th of 12 higher than 1 of 12 other Microbiome trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Microbiome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Flourish: Exploring the Early Infant Gut Microbiome
RECRUITING · NA
-
Infant Restore: Efficacy of Microbiome Analysis and Education
ACTIVE NOT RECRUITING · NA
-
IGNITE Firefighters' Health
ACTIVE NOT RECRUITING · NA
-
Alcoholic Liver Disease and the Gut Microbiome
ACTIVE NOT RECRUITING · NA
-
Maternal & Offspring Microbiome Study
ACTIVE NOT RECRUITING · NA
-
Investigating the Detection of Bovine and Soy Proteins in Human Milk
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI